Cosmos Health Inc. (COSM) Financial Statements (2024 and earlier)

Company Profile

Business Address 5 AGIOU GEORGIOU, PILEA
THESSALONIKI, 55438
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20,765293851277864783
Cash and cash equivalents 20,75028662839864783
Short-term investments157223239  
Receivables    4,9431,427
Inventory, net of allowances, customer advances and progress billings3,4523,1473,2933,4743,2033,094
Inventory3,4523,1473,2933,4743,2033,094
Prepaid expense     1,6631,482
Intangible current assets     212 
Other undisclosed current assets31,82837,43836,62917,4277,4632,725
Total current assets:56,04540,87940,77321,17918,3479,511
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization292  167
Operating lease, right-of-use asset821  498
Property, plant and equipment1,8171,8811,7571,7351,426115
Intangible assets, net (including goodwill), including:70749323126429742
Goodwill505050 (14) 
Intangible assets, net (excluding goodwill)657443181214201 
Other undisclosed intangible assets, net (including goodwill)    5011042
Other undisclosed noncurrent assets8,3576,1771,084376251,009
Total noncurrent assets:11,9948,5513,0712,7012,3481,165
TOTAL ASSETS:68,03949,42943,84423,88020,69510,676
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2762,34511,9748,5629,76911,311
Taxes payable1,325760176 1,359
Accounts payable     9,8049,952
Accrued liabilities2761,020742 (35) 
Other undisclosed accounts payable and accrued liabilities   10,4718,386  
Debt975,90213,28513,254136122
Other liabilities8621,256339165111 
Due to related parties11,9304641,6291,3761,79398
Other undisclosed current liabilities8,58419,9627,5664,88510,4652,173
Total current liabilities:21,74929,92834,79328,24122,27413,704
Noncurrent Liabilities
Long-term debt and lease obligation3,0661,322779436  
Long-term debt, excluding current maturities2,860478    
Finance lease, liability20614818883
Liabilities, other than long-term debt2,012 568109  
Other liabilities1,359 107109  
Operating lease, liability654696591353
Derivative instruments and hedges, liabilities   461   
Other undisclosed noncurrent liabilities 1,55513,10311,8661,5551,738 
Total noncurrent liabilities:6,63315,12213,2122,0991,738 
Total liabilities:28,38245,05048,00530,34024,01213,704
Equity
Equity, attributable to parent, including:39,2844,379(4,161)(6,461)(3,317)(3,028)
Preferred stock 372     
Common stock111813131413
Treasury stock, value(817)(817)612412(225)(96)
Common stock, share subscribed but unissued, subscriptions receivable(4,750)     
Additional paid in capital112,20639,67614,33313,52613,1345,652
Accumulated other comprehensive income (loss)(1,133)(152)855(16)33(1,385)
Accumulated deficit(66,233)(34,346)(18,751)(19,572)(16,273)(7,212)
Other undisclosed equity, attributable to parent (372) (1,224)(824)  
Other undisclosed equity372     
Total equity:39,6574,379(4,161)(6,461)(3,317)(3,028)
TOTAL LIABILITIES AND EQUITY:68,03949,42943,84423,88020,69510,676

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues50,34856,24055,40639,67637,08430,013
Cost of revenue(44,391)(47,909)(47,346)(36,014)(34,675)(28,057)
Cost of goods and services sold(44,391)(47,909)(47,346)(36,014)  
Gross profit:5,9578,3308,0603,6622,4091,956
Operating expenses(13,431)(12,864)(5,346)(3,918)(3,637)(6,829)
Other operating expense, net
(Other Expenses)
      (27)
Other undisclosed operating income      27
Operating income (loss):(7,474)(4,533)2,714(256)(1,228)(4,872)
Nonoperating income (expense)(5,581)(3,314)371(2,882)(314)330
Investment income, nonoperating (194)66   
Gain (loss), foreign currency transaction, before tax(413)(1,007)305(141)(314)330
Other nonoperating expense(2,425)  (2,860)  
Interest and debt expense1,004(3,431)(942)1,412(968)(748)
Income (loss) from continuing operations before equity method investments, income taxes:(12,051)(11,278)2,143(1,725)(2,510)(5,290)
Other undisclosed income (loss) from continuing operations before income taxes(1,004)3,431(945)(1,391)(6,533)(917)
Income (loss) from continuing operations before income taxes:(13,055)(7,848)1,198(3,116)(9,043)(6,207)
Income tax expense (benefit)(775)114(378)183(17)(3)
Income (loss) from continuing operations:(13,830)(7,734)821(2,933)(9,061)(6,210)
Income (loss) before gain (loss) on sale of properties:(7,734)821(2,933)(9,061)(6,210)
Other undisclosed net loss(50,115)(7,861) (366)  
Net income (loss):(63,945)(15,595)821(3,299)(9,061)(6,210)
Other undisclosed net income attributable to parent50,1157,633    
Net income (loss) attributable to parent:(13,830)(7,962)821(3,299)(9,061)(6,210)
Preferred stock dividends and other adjustments    (1,050)  
Net income (loss) available to common stockholders, basic:(13,830)(7,962)821(4,349)(9,061)(6,210)
Other undisclosed net loss available to common stockholders, diluted(50,115)(7,633)    
Net income (loss) available to common stockholders, diluted:(63,945)(15,595)821(4,349)(9,061)(6,210)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(63,945)(15,595)821(3,299)(9,061)(6,210)
Other comprehensive income (loss)  (16,601)(871)49(7,643)(6,545)
Other undisclosed comprehensive income (loss)   1,742(98)  
Comprehensive income (loss):(63,945)(32,196)1,692(3,348)(16,703)(12,754)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(981)     
Comprehensive income (loss), net of tax, attributable to parent:(64,926)(32,196)1,692(3,348)(16,703)(12,754)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: